Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Esther Hulleman

Principal Investigator

--

Phone 088 97 252 14

--

  • Gemcitabine therapeutically disrupts essential SIRT1-mediated p53 repression in atypical teratoid/rhabdoid tumors

    • sep. 2024
    • Dennis S, Metselaar, et al
    • Cell Reports Medicine
  • The heterogeneous sensitivity of pediatric brain tumors to different oncolytic viruses is predicted by unique gene expression profiles

    • apr. 2024
    • Konstantinos, Vazaios, et al
    • Molecular therapy. Oncology
  • OV Modulators of the Paediatric Brain TIME: Current Status, Combination Strategies, Limitations and Future Directions

    • jan. 2024
    • Konstantinos, Vazaios, et al
    • International Journal of Molecular Sciences
  • A road map for the treatment of pediatric diffuse midline glioma

    • nov. 2023
    • , et al
    • Cancer Cell
  • Microglia in pediatric brain tumors

    • nov. 2023
    • Aimée, du Chatinier, et al
    • Cell Reports Medicine
View all publications